Related Experiment Videos
Cryodetector mass spectrometry profiling of plasma samples for HELLP diagnosis: an exploratory study
Cornelia Koy1, Juliane C Heitner, Ralf Woisch
1Proteome Center Rostock, University of Rostock, Joachim-Jungius-Strasse 9, D-10859 Rostock, Germany.
Proteomics
|July 16, 2005
Summary
A new cryodetector mass spectrometry method rapidly screens for hemolysis, elevated liver enzymes, and low platelets syndrome (HELLP). This assay accurately distinguishes HELLP patients from healthy individuals, aiding in early diagnosis.
Area of Science:
- Biochemistry
- Proteomics
- Clinical Diagnostics
Background:
- Hemolysis, elevated liver enzymes, and low platelets syndrome (HELLP) is a severe condition complicating pregnancy.
- Accurate and rapid diagnostic methods for HELLP are crucial for timely intervention and improved patient outcomes.
Purpose of the Study:
- To develop and validate a cryodetector mass spectrometry (MS)-based screening assay for the rapid and reliable identification of HELLP patients.
- To compare plasma protein profiles of HELLP patients with healthy pregnant and nonpregnant controls.
Main Methods:
- Plasma protein abundances were analyzed using a TOF mass spectrometer with a cryodetector system.
- Spectra were reproducible under constant acquisition conditions.
- Peak areas of ten selected ion signals were statistically analyzed to identify differences between HELLP and control groups.
Main Results:
- Significant differences in ion intensities were observed between HELLP patients and controls, notably the 11.8 kDa ion signal (likely serum amyloid A).
- The assay achieved a sensitivity of 87.5% and specificity of 100% in distinguishing HELLP from non-HELLP samples.
- Positive and negative predictive values were 100% and 95.6%, respectively.
Conclusions:
- Cryodetector MS-based screening offers a rapid, reliable, and accurate method for HELLP diagnosis.
- The assay demonstrates high sensitivity and specificity, with excellent predictive values.
- This method can significantly aid in the early detection and management of HELLP syndrome.